5 employees
Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.
2019
Ancilia Biosciences raised undisclosed on December 14, 2020
Investors: Bioverge
Ancilia Biosciences raised undisclosed on July 6, 2020
Investors: Harmonix